Xia RH - Search Results

1

A pilot study of neoadjuvant combination of anti-PD-1 camrelizumab and VEGFR2 inhibitor apatinib for locally advanced resectable oral squamous cell carcinoma.

Ju WT, Xia RH, Zhu DW, Dou SJ, Zhu GP, Dong MJ, Wang LZ, Sun Q, Zhao TC, Zhou ZH, Liang SY, Huang YY, Tang Y, Wu SC, Xia J, Chen SQ, Bai YZ, Li J, Zhu Q, Zhong LP. Ju WT, et al. Among authors: xia rh. Nat Commun. 2022 Sep 14;13(1):5378. doi: 10.1038/s41467-022-33080-8. Nat Commun. 2022. PMID: 36104359 Free PMC article. Clinical Trial.

2

[Effect of DNA methyltransferases 1 inhibition on proliferation, invasion, and metastasis in ACC-M line].

Huang FH, Tian Z, Zhang CY, Xia RH, Li J. Huang FH, et al. Among authors: xia rh. Zhonghua Kou Qiang Yi Xue Za Zhi. 2009 Dec;44(12):745-50. Zhonghua Kou Qiang Yi Xue Za Zhi. 2009. PMID: 20193293 Chinese.

3

EZH2 promotes malignant phenotypes and is a predictor of oral cancer development in patients with oral leukoplakia.

Cao W, Younis RH, Li J, Chen H, Xia R, Mao L, Chen W, Ren H. Cao W, et al. Among authors: xia r. Cancer Prev Res (Phila). 2011 Nov;4(11):1816-24. doi: 10.1158/1940-6207.CAPR-11-0130. Epub 2011 Jun 22. Cancer Prev Res (Phila). 2011. PMID: 21697275 Free PMC article. Clinical Trial.

4

Adenoid cystic carcinoma of the head and neck: clinicopathologic analysis of 218 cases in a Chinese population.

Zhang CY, Xia RH, Han J, Wang BS, Tian WD, Zhong LP, Tian Z, Wang LZ, Hu YH, Li J. Zhang CY, et al. Among authors: xia rh. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 Mar;115(3):368-75. doi: 10.1016/j.oooo.2012.11.018. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013. PMID: 23453028

5

The combination of SMAD4 expression and histological grade of dysplasia is a better predictor for the malignant transformation of oral leukoplakia.

Xia RH, Song XM, Wang XJ, Li J, Mao L. Xia RH, et al. PLoS One. 2013 Jun 24;8(6):e66794. doi: 10.1371/journal.pone.0066794. Print 2013. PLoS One. 2013. PMID: 23826135 Free PMC article.

6

Ebp1 activates podoplanin expression and contributes to oral tumorigenesis.

Mei Y, Zhang P, Zuo H, Clark D, Xia R, Li J, Liu Z, Mao L. Mei Y, et al. Oncogene. 2014 Jul 17;33(29):3839-50. doi: 10.1038/onc.2013.354. Epub 2013 Aug 26. Oncogene. 2014. PMID: 23975429

7

Common and complex Notch1 mutations in Chinese oral squamous cell carcinoma.

Song X, Xia R, Li J, Long Z, Ren H, Chen W, Mao L. Song X, et al. Clin Cancer Res. 2014 Feb 1;20(3):701-10. doi: 10.1158/1078-0432.CCR-13-1050. Epub 2013 Nov 25. Clin Cancer Res. 2014. PMID: 24277457 Free PMC article.

8

High expression of H3K9me3 is a strong predictor of poor survival in patients with salivary adenoid cystic carcinoma.

Xia R, Zhou R, Tian Z, Zhang C, Wang L, Hu Y, Han J, Li J. Xia R, et al. Arch Pathol Lab Med. 2013 Dec;137(12):1761-9. doi: 10.5858/arpa.2012-0704-OA. Arch Pathol Lab Med. 2013. PMID: 24283856 Free article.

9

RASSF1A promoter hypermethylation is a strong biomarker of poor survival in patients with salivary adenoid cystic carcinoma in a Chinese population.

Zhang CY, Zhao YX, Xia RH, Han J, Wang BS, Tian Z, Wang LZ, Hu YH, Li J. Zhang CY, et al. Among authors: xia rh. PLoS One. 2014 Oct 10;9(10):e110159. doi: 10.1371/journal.pone.0110159. eCollection 2014. PLoS One. 2014. PMID: 25302792 Free PMC article.

10

Low expression of endothelin receptor B (EDNRB) is related to H3K9me3 binding with the EDNRB promoter region and is associated with the clinical T tumor stage in salivary adenoid cystic carcinoma.

Xia RH, Wang Z, Zhang CY, Hu YH, Zhou RR, Wang LZ, Tian Z, Li J. Xia RH, et al. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015 Aug;120(2):258-68. doi: 10.1016/j.oooo.2015.04.015. Epub 2015 May 13. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015. PMID: 26166030

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

74 results

Search Page